Follow the JW신약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, JW신약 has published 24 insider filings. Market capitalisation: €94.5bn. The latest transaction was reported on 5 March 2026 (Other). Among the most active insiders: JW홀딩스. All data is accessible without an account.
24
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,020 of 29,063 companies
81.1
score / 100
Value
82
Quality
80
FCF yld4.7%
Earn yld17%
EV/EBITDA5.9x
ROE·
Gross mgn50%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.